The following are
major risk factors for fragility factors :
Low bone density
History of fragility fractures
Family history of osteoporosis
Smoking
Body weight less than 127 pounds
Medications used for improving BMD : Bone Mineral Density
Following medications are used to improve BMD and hence to
reduce risk of fragility fractures.
Calcium and Vitamin D
supplementation
Adequate vitamin D supplementation and Calcium is the single
most important intervention for prevention of osteoporosis.
Anti-resorptive
medications/Alendronate :
These are indicated to prevent risk of fragility fractures.
This is a bisphosphonate.
It improves BMD by reducing bone resorption.
It specifically increases BMD at the hip and lumbar spine.
Another example of bisphosphonates is risedronate which is
also used for treatment of osteoporosis but it has more GI side effects.
Calcitonin
This also inhibits bone resorption
It causes improvement in vertebral BMD and hence reduces the
incidence of vertebral fractures.
It has slight analgesic effect as well and hence can reduce
pain from vertebral fracture.
PTH subcutaneous injections/Parathyroid hormone:
This is very effective in increasing BMD at the lumbar spine
and in significantly reducing the incidence of vertebral fractures.
It is an expensive treatment and is used only if a failure by
bisphosphonates to improve BMD occurs.
HRT is no longer used for treatment of post menopausal
osteoporosis due to it causing increased risk of the following :
Stroke
DVT and Pulmonary embolism
Myocardial infarction
Ca breast